AU2001251115A1 - Use of locally applied dna fragments - Google Patents
Use of locally applied dna fragmentsInfo
- Publication number
- AU2001251115A1 AU2001251115A1 AU2001251115A AU5111501A AU2001251115A1 AU 2001251115 A1 AU2001251115 A1 AU 2001251115A1 AU 2001251115 A AU2001251115 A AU 2001251115A AU 5111501 A AU5111501 A AU 5111501A AU 2001251115 A1 AU2001251115 A1 AU 2001251115A1
- Authority
- AU
- Australia
- Prior art keywords
- dna fragments
- locally applied
- applied dna
- locally
- fragments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09540843 | 2000-03-31 | ||
US09/540,843 US7094766B1 (en) | 1995-06-06 | 2000-03-31 | Use of locally applied DNA fragments |
PCT/US2001/010162 WO2001074342A2 (en) | 2000-03-31 | 2001-03-30 | Use of locally applied dna fragments |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001251115A1 true AU2001251115A1 (en) | 2001-10-15 |
Family
ID=24157158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001251115A Abandoned AU2001251115A1 (en) | 2000-03-31 | 2001-03-30 | Use of locally applied dna fragments |
Country Status (5)
Country | Link |
---|---|
US (2) | US7033829B2 (de) |
EP (2) | EP1274410A2 (de) |
AU (1) | AU2001251115A1 (de) |
HK (1) | HK1054184A1 (de) |
WO (1) | WO2001074342A2 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030032610A1 (en) * | 1996-06-03 | 2003-02-13 | Gilchrest Barbara A. | Method to inhibit cell growth using oligonucleotides |
AU2001262108A1 (en) * | 2000-03-17 | 2001-09-24 | Unilever Plc | Non-physiologic dna fragments for tanning skin |
AU2001251115A1 (en) * | 2000-03-31 | 2001-10-15 | Trustees Of Boston University | Use of locally applied dna fragments |
AU2001264317A1 (en) * | 2000-06-20 | 2002-01-02 | Koken Co., Ltd. | Preparations for oligonucleotide transfer |
CN1313158C (zh) * | 2001-06-20 | 2007-05-02 | 大日本住友制药株式会社 | 促进核酸转移的方法 |
WO2005061717A1 (ja) * | 2003-12-19 | 2005-07-07 | Dainippon Sumitomo Pharma Co., Ltd. | 新規な核酸導入法 |
CN1989439B (zh) * | 2004-05-06 | 2010-12-29 | 美国政府健康及人类服务部 | 治疗葡萄膜炎的方法以及组合物 |
JP2007537758A (ja) * | 2004-05-19 | 2007-12-27 | トラスティーズ オブ ボストン ユニバーシティ | Wrn媒介性テロメア開始型細胞シグナル伝達の調節 |
BG65639B1 (bg) * | 2004-06-25 | 2009-04-30 | Диана СТЕФАНОВА | Регенериращ състав |
US20090062184A1 (en) * | 2005-03-24 | 2009-03-05 | Dainippon Sumitomo Pharma Co., Ltd. | Fine particulate preparation comprising complex of nucleic acid molecule and collagen |
EP1871388A4 (de) * | 2005-04-04 | 2010-10-27 | Univ Boston | Verfahren zum schutz vor oxidativem stress |
EP3329004B1 (de) | 2015-07-29 | 2020-01-15 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Therapeutische oligonukleotide |
EP3124609A1 (de) | 2015-07-29 | 2017-02-01 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Therapeutische oligonukleotide |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3937809A (en) * | 1974-05-01 | 1976-02-10 | Kolmar Laboratories, Inc. | Addition compound of a nucleotide and an amino acid and the use thereof in protection against actinic radiation |
FR2439013A1 (fr) * | 1978-10-19 | 1980-05-16 | Serobiologiques Lab Sa | Composition, utilisable notamment comme produit cosmetique permettant un bronzage de la peau, comprenant l'emploi d'acides amines |
CA1200773A (en) | 1980-02-29 | 1986-02-18 | William J. Rutter | Expression linkers |
FR2521565B1 (fr) | 1982-02-17 | 1985-07-05 | Dior Sa Parfums Christian | Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees |
FR2534487B1 (fr) | 1982-10-15 | 1988-06-10 | Dior Christian Parfums | Procede d'homogeneisation de dispersions de phases lamellaires lipidiques hydratees, et suspensions obtenues par ce procede |
US5162217A (en) * | 1984-08-27 | 1992-11-10 | Bio-Technology General Corp. | Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof |
US6103243A (en) * | 1985-05-15 | 2000-08-15 | Biotechnology Australia Pty, Ltd | Oral vaccines |
US5256648A (en) * | 1988-01-21 | 1993-10-26 | Yale University | Selective inhibition of gene expression by photoactivatable oligonucleotides |
US5077211A (en) | 1988-07-06 | 1991-12-31 | Applied Genetics, Inc. | Purification and administration of dna repair enzymes |
US5173397A (en) | 1989-03-28 | 1992-12-22 | Mitsubishi Paper Mills Limited | Photographic support with titanium dioxide pigmented polyolefin layer |
US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
US5976789A (en) | 1991-07-17 | 1999-11-02 | Bio Merieux | System of probes enabling HLA-DR typing to be performed, and typing method using said probes |
WO1993009788A1 (en) | 1991-11-13 | 1993-05-27 | Baylor College Of Medicine | Triplex forming oligonucleotide reagents targeted to the neu oncogene promoter and method of use |
WO1993018176A1 (en) * | 1992-03-11 | 1993-09-16 | Dana-Farber Cancer Institute | METHODS TO CLONE mRNA |
EP0644933A4 (de) | 1992-04-30 | 1997-06-25 | Baylor College Medicine | Konstitutives und induziebares vektorsystem für die epidermis. |
US6007989A (en) * | 1992-05-13 | 1999-12-28 | Board Of Regents, The University Of Texas System | Methods of screening for compounds that derepress or increase telomerase activity |
US5686306A (en) * | 1992-05-13 | 1997-11-11 | Board Of Regents, The University Of Texas System | Methods and reagents for lengthening telomeres |
US5489508A (en) * | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
US5645986A (en) * | 1992-05-13 | 1997-07-08 | Board Of Reagents, The University Of Texas System | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
US5585479A (en) * | 1992-07-24 | 1996-12-17 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human ELAM-I RNA |
US5470577A (en) * | 1993-07-07 | 1995-11-28 | Trustees Of Boston University | Stimulation of tanning by DNA fragments or single-stranded DNA |
US5527675A (en) | 1993-08-20 | 1996-06-18 | Millipore Corporation | Method for degradation and sequencing of polymers which sequentially eliminate terminal residues |
GB9318751D0 (en) | 1993-09-09 | 1993-10-27 | Health Lab Service Board | Detection and speciation of campylobacter |
DE4331012A1 (de) | 1993-09-13 | 1995-03-16 | Bayer Ag | Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik |
ATE223428T1 (de) | 1993-09-29 | 2002-09-15 | Nabi | Nukleoside und nukleotide mit vergrösserten ringen |
US5958680A (en) * | 1994-07-07 | 1999-09-28 | Geron Corporation | Mammalian telomerase |
US5583016A (en) * | 1994-07-07 | 1996-12-10 | Geron Corporation | Mammalian telomerase |
AU700903B2 (en) * | 1994-10-12 | 1999-01-14 | Focal, Inc. | Targeted delivery via biodegradable polymers |
US5643890A (en) | 1995-01-31 | 1997-07-01 | The Board Of Regents Of The University Of Nebraska | Synthetic oligonucleotides which mimic telomeric sequences for use in treatment of cancer and other diseases |
FI100556B (fi) * | 1995-03-01 | 1997-12-31 | Biohit Oyj | Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten |
US5858987A (en) * | 1995-05-05 | 1999-01-12 | Mitotix, Inc. | E6AP antisense constructs and methods of use |
US6147056A (en) * | 1995-06-06 | 2000-11-14 | Trustees Of Boston University | Use of locally applied DNA fragments |
US5955059A (en) * | 1995-06-06 | 1999-09-21 | Trustees Of Boston University | Use of locally applied DNA fragments |
US7094766B1 (en) * | 1995-06-06 | 2006-08-22 | Trustees Of Boston University | Use of locally applied DNA fragments |
US5733730A (en) | 1995-08-25 | 1998-03-31 | The Rockefeller University | Telomere repeat binding factor and diagnostic and therapeutic use thereof |
US6015710A (en) * | 1996-04-09 | 2000-01-18 | The University Of Texas System | Modulation of mammalian telomerase by peptide nucleic acids |
US6022863A (en) | 1996-05-21 | 2000-02-08 | Yale University | Regulation of gene expression |
US5917019A (en) | 1997-02-13 | 1999-06-29 | The Rockefeller University | Altered telomere repeat binding factor 2 |
WO1999003507A1 (en) | 1997-07-17 | 1999-01-28 | Board Of Regents Of The University Of Nebraska | Telomere mimetic compounds and methods of use for same |
US5998175A (en) * | 1998-07-24 | 1999-12-07 | Lumigen, Inc. | Methods of synthesizing and amplifying polynucleotides by ligation of multiple oligomers |
US6130088A (en) * | 1999-07-20 | 2000-10-10 | Isis Pharmaceuticals Inc. | Antisense modulation of telomeric repeat binding factor 1 expression |
DK1210357T3 (da) | 1999-09-10 | 2008-07-21 | Geron Corp | Oligonukleotid-N3' -P5' -thiophosphoramidater: syntese og anvendelse deraf |
US6140125A (en) * | 1999-10-15 | 2000-10-31 | Isis Pharmaceuticals Inc. | Antisense inhibition of bcl-6 expression |
JP2001142181A (ja) * | 1999-11-10 | 2001-05-25 | Fuji Photo Film Co Ltd | ハロゲン化銀カラーリバーサル写真感光材料及びこれを用いるカラー画像形成方法 |
AU2001251115A1 (en) * | 2000-03-31 | 2001-10-15 | Trustees Of Boston University | Use of locally applied dna fragments |
US7358040B2 (en) * | 2001-08-01 | 2008-04-15 | Rigel Pharmaceuticals, Incorporated | MRE 11: modulation of cellular proliferation |
KR101017483B1 (ko) * | 2001-08-17 | 2011-02-25 | 바이오니취 라이프 사이언시즈 인코포레이티드 | 올리고뉴클레오타이드 조성물 및 세포사멸을 유도하기위한 그의 용도 |
-
2001
- 2001-03-30 AU AU2001251115A patent/AU2001251115A1/en not_active Abandoned
- 2001-03-30 WO PCT/US2001/010162 patent/WO2001074342A2/en active Application Filing
- 2001-03-30 EP EP01924464A patent/EP1274410A2/de not_active Withdrawn
- 2001-03-30 EP EP10011135A patent/EP2363133A1/de not_active Withdrawn
-
2002
- 2002-04-12 US US10/122,633 patent/US7033829B2/en not_active Expired - Fee Related
-
2003
- 2003-07-15 HK HK03105110.1A patent/HK1054184A1/zh unknown
-
2006
- 2006-04-24 US US11/409,706 patent/US20060183704A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7033829B2 (en) | 2006-04-25 |
WO2001074342A3 (en) | 2002-03-28 |
EP2363133A1 (de) | 2011-09-07 |
HK1054184A1 (zh) | 2003-11-21 |
US20060183704A1 (en) | 2006-08-17 |
EP1274410A2 (de) | 2003-01-15 |
WO2001074342A2 (en) | 2001-10-11 |
US20030032611A1 (en) | 2003-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1247815A3 (de) | Modifizierte Oligonukleotide sowie deren Verwendung | |
AU2001278142A1 (en) | Common application metamodel including c/c++ metamodel | |
AU2002223827A1 (en) | Well treatment | |
AU2002359163A1 (en) | New use | |
AU2001210146A1 (en) | Determination of deformation of surgical tools | |
AU2001294549A1 (en) | Process and intermediates | |
AU2001259702A1 (en) | Tissue regrafting | |
AU2733200A (en) | Dna mobility modifier | |
AU2002224553A1 (en) | Human proteases | |
AU2001251115A1 (en) | Use of locally applied dna fragments | |
AU2001237992A1 (en) | Purification of oligonucleotides | |
AU2002231206A1 (en) | Treatment of depression | |
AU2001288972A1 (en) | Antipsychotic sulfonamide-heterocycles, and methods of use thereof | |
AU2001266225A1 (en) | Decondensation of dna | |
GB9906758D0 (en) | Use of locally applied dna fragments | |
AU2001295841A1 (en) | Human dna sequences | |
AU2002211373A1 (en) | Haplotypes of the por gene | |
AU2001245414A1 (en) | Treatment of allergies | |
AU2001285155A1 (en) | Polymorphic dna fragments and uses thereof | |
AU2001256161A1 (en) | Nail | |
AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines | |
AU2001253560A1 (en) | Methods of treatment | |
AU2002347346A1 (en) | Dna vaccine | |
AU2002329425A1 (en) | Dna sequencer | |
AU2001240017A1 (en) | Human enzyme molecules |